Corvus Pharmaceuticals, Inc.

Invesco Ltd. CRVS
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/12/2026
Shares
38,212
Value ($000)
559
Weight
0.0%
2023 Q2 - 2026 Q1 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).